New research in PLOS Biology links dopamine imbalance to social difficulties in Parkinson's and schizophrenia, suggesting dopamine-based drugs as potential treatments.

Dopamine imbalance may directly cause social difficulties in disorders such as Parkinson's and schizophrenia, finds new research published in PLOS Biology, suggesting that dopamine-based drugs could potentially treat social challenges in these conditions. The study provides further insight into the role of dopamine in regulating social abilities and understanding emotions of others.